Piper Sandler Maintains Overweight on Marathon Oil, Lowers Price Target to $38
Piper Sandler analyst Mark Lear maintains Marathon Oil (NYSE:MRO) with a Overweight and lowers the price target from $39 to $38.
Related Posts
Tesla, IONQ, Nano-X, Peloton, Hepion: Why These 5 Stocks Are Drawing Investors’ Attention Today
U.S. markets ended mixed on Thursday with the S&P 500 and the Dow Jones recording losses dragged by…
SOPHiA GENETICS Enhances RareCyte Precision Biology Services Portfolio With SOPHiA DDM
RareCyte will use the SOPHiA DDM™ Platform to support its oncology testing panelBOSTON and ROLLE, Switzerland, Jan. 18, 2024 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ:SOPH), a cloud-native software company and a
O-I Glass Subsidiary OI European Group BV Launches €400M Senior Notes Offering
O-I Glass, Inc. (the "Company") announced that OI European Group B.V. ("OIEG"), an indirect wholly owned subsidiary of the Company, intends to offer, subject to market and other conditions, €400